Research-Ready With >300 Clinical Sites

The PTN has worked with over 300 clinical research sites, including leading pediatric hospitals and academic institutions. This assembly of experienced, research-ready sites allows for efficient study startup and conduct. Trial infrastructure remains in place from one study to the next, conserving resources.

Infrastructure That Makes Difficult Research Possible

Pediatric research presents special challenges, such as:

• Need for specialized clinical and pharmacology expertise
• Difficulty testing very small amounts of blood and other biological samples
• Ethical concerns with research involving children

The PTN provides scientific, technical, and administrative infrastructure to ensure that trials obtain valid results in a safe, ethical, and efficient manner.

PTN Steering Committee

• Danny Benjamin, MD, PhD, MPH, Duke University
• John Costello, MD, MPH, Medical University of South Carolina
• Amanda England, MD, Ochsner Health
• Rachel G. Greenberg, MD, MB, MHS, Duke University
• Chi Hornik, MD, PhD, Duke University
• Bridgette Jones, MD, MSCR, Children's Mercy Kansas City
• Gregory Kearns, Pharm D, PhD, Texas Christian University
• Tamorah Lewis, MD, PhD, SickKids
• Ian Paul, MD, Penn State University
• Uma Subrayan, BS, MS, Tulane University School of Medicine
• Janice Sullivan, MD, University of Louisville
• Kelly Wade, MD, PhD, MSCE, Children's Hospital of Philadelphia
• Leanne West, PhD, Internal Children's Advisory Network (iCAN)

Other Collaborators

• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• Best Pharmaceuticals for Children Act (BPCA) Program
• The Emmes Company, LLC (Coordinating Center)
• Thermo Fisher Scientific (Biological Specimens Repository)